California asks FDA to undo limits on abortion pill mifepristone amid RFK Jr. scrutiny
latimes.comPublished: 6/5/2025
Summary
Mifepristone, a widely used abortion medication in the U.S., has sparked a fight for access as California and other states seek to overturn strict FDA regulations. The most common method of terminating pregnancies, mifepristone has faced scrutiny from antiabortion groups and is currently restricted under the Trump administration's "Make America Healthy Again" initiative. Attorneys general argue it’s safe but face legal challenges, including requirements for prescribers’ names and tracking that could deter healthcare providers. The states hope to block these measures while protecting reproductive freedom.